Clinical Trials Directory

Trials / Completed

CompletedNCT05291325

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy

Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy: a Multicenter, Randomized, Controlled Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,607 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The clinical purpose of this study was to investigate whether the adjuvant application of linaclotide in bowel preparation for colonoscopy could improve the quality of bowel preparation or reduce the dosage of laxatives.

Conditions

Interventions

TypeNameDescription
DRUG3L PEG + LinaclotideBefore colonoscopy, particpant take linaclotide capsules for 3 days (1 tablet should be taken at least 30 minutes before the first meal every day). Particpant take 1500ml polyethylene glycol electrolyte solution within 1.5 hours from 20 p.m the night before the examination; and repeat the same dose of polyethylene glycol electrolyte solution 4-6 hours before colonoscopy.
DRUG3L PEGParticpant take 1500ml polyethylene glycol electrolyte solution within 1.5 hours from 20 p.m the night before the examination; and repeat the same dose of polyethylene glycol electrolyte solution 4-6 hours before colonoscopy.
DRUG2L PEG + LinaclotideBefore colonoscopy, particpant take linaclotide capsules for 3 days (1 tablet should be taken at least 30 minutes before the first meal every day). Particpant take 1000ml polyethylene glycol electrolyte solution within 1 hours from 20 p.m the night before the examination; and repeat the same dose of polyethylene glycol electrolyte solution 4-6 hours before colonoscopy.

Timeline

Start date
2022-05-25
Primary completion
2023-08-30
Completion
2024-04-28
First posted
2022-03-22
Last updated
2024-06-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05291325. Inclusion in this directory is not an endorsement.